Chest
Volume 129, Issue 3, March 2006, Pages 501-503
EditorialsIs Sustained Pharmacologic Lung Volume Reduction Now Possible in COPD?
References (18)
- et al.
Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD
Chest
(2005) - et al.
Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation
Chest
(2002) - et al.
Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes
Chest
(2003) - et al.
Combining salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial
Lancet
(2003) - et al.
Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD
Chest
(2002) - et al.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary
Am J Respir Crit Care Med
(2001) - et al.
Standardisation of spirometry
Eur Respir J
(2005) - et al.
Spirometric correlates of improvement in exercise performance after anticholinergic therapy in COPD
Am J Respir Crit Care Med
(1999) - et al.
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
Eur Respir J
(2004)
There are more references available in the full text version of this article.
Cited by (0)
Dr. O’Donnell has no real or potential financial or personal conflict of interest on this topic.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).
Copyright © 2006 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.